GRI increases its portfolio of agencies and products with the addition of sole UK distributorship for the Finnzymes PCR and transposon product range
At the cutting edge of PCR and transposon technologies, Finnzymes' enzyme products will complement GRI's range of market leading molecular biology instrumentation.
GRI will act as the sole UK agent for Finnzymes resulting in unprecedented product knowledge and technical support.
High quality science is the backbone of Finnzymes' success.
With an aim to provide new molecular biology products of extreme purity to the scientific community, Finnzymes has continuously developed its product range to provide the best enzymes currently on offer. This commitment to developing novel enzymes for molecular biology has resulted in Finnzymes being recognised as the most innovative new company in Finland.
Finnzymes' range covers products for PCR including a variety of thermostable DNA polymerases, RT-PCR kits and also DNA and RNA modifying enzymes.
In addition, the molecular mechanisms of transposable elements of DNA called 'Jumping Genes' will see transposon-based products offer new directions to traditional methods used in molecular biology.
At present, transposon products include the Template Generation System (TGS), a novel method for preparing templates for sequencing DNA, and the Mutation Generation System (MGS), which offers a transposon based system for insertion scanning mutatgenesis.
The complete range of Finnzymes products will compliment GRI's portfolio of molecular biology instrumentation.
GRI's Molecular Biology Division will promote Finnzymes in the UK biotechnology market place with support from in house application and product specialists.
